- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant monoclonal antibody to human serum amyloid P com
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant monoclonal antibody to human serum amyloid P component
| EU orphan designation number: | EU/3/14/1293
|
| Active ingredient: | Recombinant monoclonal antibody to human serum amyloid P component |
| Indication: | Treatment of AL amyloidosis |
| Sponsor: | GlaxoSmithKline Trading Services Limited
Currabinny, Carrigaline, County Cork, Ireland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 01/08/2014 | Orphan designation | EMA/OD/021/14 | (2014)5572 of 30/07/2014 |
CONTACT
EU links
Directorate General Health & Consumers